Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease.
Saved in:
| Title: | Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. |
|---|---|
| Authors: | Polyzos SA; First Laboratory of Pharmacology, School of Medicine, Campus of Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. spolyzos@auth.gr., Goulis DG; Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Giouleme O; 2nd Propedeutic Department of Internal Medicine, Hippocration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Germanidis GS; 1st Department of Internal Medicine, AHEPA University Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Goulas A; First Laboratory of Pharmacology, School of Medicine, Campus of Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. |
| Source: | Current obesity reports [Curr Obes Rep] 2022 Sep; Vol. 11 (3), pp. 166-179. Date of Electronic Publication: 2022 May 02. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Current Medicine Group Country of Publication: United States NLM ID: 101578283 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-4968 (Electronic) Linking ISSN: 21624968 NLM ISO Abbreviation: Curr Obes Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
